Amarin Corporation PLC (NASDAQ:AMRN)

19.91
Delayed Data
As of Jan 17
 -0.15 / -0.75%
Today’s Change
13.76
Today|||52-Week Range
26.12
-7.14%
Year-to-Date
Good News for Amarin: AstraZeneca Abandoning its Fish Oil Pill
Jan 13 / MotleyFool.com - Paid Partner Content
Here's Why Matinas BioPharma Shares Lost as Much as 16.9% Today
Jan 07 / MotleyFool.com - Paid Partner Content
2020 J.P. Morgan Healthcare Conference Roundup
Jan 13 / MotleyFool.com - Paid Partner Content
Amarin Reports Preliminary Vascepa Sales, Projects Further Growth In 2020
Jan 07 / MotleyFool.com - Paid Partner Content
All the 2020 Pre-JPM News Healthcare Investors Need to Know
Jan 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close20.06
Today’s open20.08
Day’s range19.74 - 20.21
Volume5,531,650
Average volume (3 months)9,221,609
Market cap$7.2B
Data as of 3:59pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)-54.77%
Earnings growth (this year)+72.33%
Earnings growth (next 5 years)+28.40%
Revenue growth (last year)+25.01%
P/E ratioNM
Price/Sales17.68
Price/Book50.12

Competitors

 Today’s
change
Today’s
% change
PRAHPRA Health Sciences ...-0.11-0.10%
SYNHSyneos Health Inc+0.13+0.20%
CRLCharles River Labora...-0.18-0.11%
EXELExelixis Inc-0.62-3.03%
Data as of 6:30pm ET, 01/17/2020

Financials

Next reporting dateMarch 3, 2020
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$228.8M
Annual profit (last year)-$116.2M
Net profit margin-50.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts